Fox Jonathan C - Jul 1, 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Stock symbol
EWTX
Transactions as of
Jul 1, 2025
Transactions value $
$0
Form type
4
Date filed
7/2/2025, 04:18 PM
Previous filing
Jun 18, 2025
Next filing
Oct 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fox Jonathan C Director C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER /s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C 2025-07-02 0001655016

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Award $0 +858 +7.52% $0.00 12.3K Jul 1, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. (the "Issuer") common stock, granted and released to the reporting person on July 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the the Issuer's Outside Director Compensation Policy, as amended.